Common Contracts

OPTION AND LICENSE AGREEMENT

Option and License Agreement • October 25th, 2013 • Xencor Inc • Pharmaceutical preparations

• Contract Type
  Option and License Agreement
• Filed
  October 25th, 2013
• Company
  Xencor Inc
• Industry
  Pharmaceutical preparations

This OPTION AND LICENSE AGREEMENT (this “Agreement”), effective as of January 28, 2013 (the “Effective Date”), is made by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (“Alexion”), having a principal place of business at 352 Knotter Drive, Cheshire, Connecticut 06410, and Xencor, Inc., a Delaware corporation (“Xencor”), having a principal place of business at 111 West Lemon Avenue, Monrovia, California 91016. Alexion and Xencor may each be referred to herein, individually, as a “Party” or, collectively, as the “Parties.”

OPTION AND LICENSE AGREEMENT

Option and License Agreement • October 11th, 2013 • Xencor Inc • Pharmaceutical preparations

• Contract Type
  Option and License Agreement
• Filed
  October 11th, 2013
• Company
  Xencor Inc
• Industry
  Pharmaceutical preparations

This OPTION AND LICENSE AGREEMENT (this “Agreement”), effective as of January 28, 2013 (the “Effective Date”), is made by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (“Alexion”), having a principal place of business at 352 Knotter Drive, Cheshire, Connecticut 06410, and Xencor, Inc., a Delaware corporation (“Xencor”), having a principal place of business at 111 West Lemon Avenue, Monrovia, California 91016. Alexion and Xencor may each be referred to herein, individually, as a “Party” or, collectively, as the “Parties.”

OPTION AND LICENSE AGREEMENT

Option and License Agreement • September 11th, 2013 • Xencor Inc • Pharmaceutical preparations

• Contract Type
  Option and License Agreement
• Filed
  September 11th, 2013
• Company
  Xencor Inc
• Industry
  Pharmaceutical preparations

This OPTION AND LICENSE AGREEMENT (this “Agreement”), effective as of January 28, 2013 (the “Effective Date”), is made by and between Alexion Pharmaceuticals, Inc., a Delaware corporation (“Alexion”), having a principal place of business at 352 Knotter Drive, Cheshire, Connecticut 06410, and Xencor, Inc., a Delaware corporation (“Xencor”), having a principal place of business at 111 West Lemon Avenue, Monrovia, California 91016. Alexion and Xencor may each be referred to herein, individually, as a “Party” or, collectively, as the “Parties.”